ATXA Therapeutics and PAH-Hope team members, Prof. Therese Kinsella & Dr. Helen Reid are looking forward to the ESC Congress 2019 next week. They will be onsite presenting preclinical findings of NTP42 for the treatment of PAH (Pulmonary Arterial Hytertension).
ESC Congress 2019
together with World Congress of Cardiology
Saturday 31 August - Wednesday 4 September 2019
Paris - France